Zika virus-related neurotropic flaviviruses infect human placental explants and cause fetal demise in mice

Science Translational Medicine

Volumn 10, Issue 426, 2018, Pages

  Platt, Derek J ^a   Smith, Amber M ^a   Arora, Nitin ^b   Diamond, Michael S ^a   Coyne, Carolyn B ^b   Miner, Jonathan J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CENTRAL NERVOUS SYSTEM; CHIKUNGUNYA; CHIKUNGUNYA VIRUS; CHORION VILLUS; CONTROLLED STUDY; DECIDUA; EXPLANT; FEMALE; FETUS DEATH; FETUS MEMBRANE; FLAVIVIRUS; FLAVIVIRUS INFECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENCE; IN SITU HYBRIDIZATION; MAYARO VIRUS; MAYARO VIRUS INFECTION; MOUSE; NONHUMAN; PLACENTA; PLACENTA DISORDER; POWASSAN VIRUS; POWASSAN VIRUS INFECTION; PRIORITY JOURNAL; RNA ANALYSIS; SECOND TRIMESTER PREGNANCY; VERTICAL TRANSMISSION; VIRUS INFECTION; VIRUS TRANSMISSION; WEST NILE VIRUS; WEST NILE VIRUS INFECTION; ZIKA VIRUS; ANIMAL; COMPLICATION; PATHOGENICITY; PREGNANCY; TICK BORNE ENCEPHALITIS VIRUS; VIROLOGY;

ANIMALS; ENCEPHALITIS VIRUSES, TICK-BORNE; FEMALE; FETAL DEATH; FLAVIVIRUS; FLAVIVIRUS INFECTIONS; HUMANS; MICE; PLACENTA; PREGNANCY; WEST NILE VIRUS; ZIKA VIRUS;

EID: 85041665082     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.aao7090     Document Type: Article

References (57)

1. G. W. A. Dick, S. F. Kitchen, A. J. Haddow, Zika virus. I. Isolations and serological specificity. Trans. R. Soc. Trop. Med. Hyg. 46, 509-520 (1952).
2. W. K. de Oliveira, G. V. A. de França, E. H. Carmo, B. B. Duncan, R. de Souza Kuchenbecker, M. I. Schmidt, Infection-related microcephaly after the 2015 and 2016 Zika virus outbreaks in Brazil: A surveillance-based analysis. Lancet 390, 861-870 (2017).
3. S. C. Weaver, Emergence of epidemic Zika virus transmission and congenital Zika syndrome: Are recently evolved traits to blame? mBio 8, e02063-e16 (2017).
4. D. G. Widman, E. Young, B. L. Yount, K. S. Plante, E. N. Gallichotte, D. L. Carbaugh, K. M. Peck, J. Plante, J. Swanstrom, M. T. Heise, H. M. Lazear, R. S. Baric, A reverse genetics platform that spans the Zika virus family tree. mBio 8, e02014-e16 (2017).
5. L. Yuan, X.-Y. Huang, Z.-Y. Liu, F. Zhang, X.-L. Zhu, J.-Y. Yu, X. Ji, Y.-P. Xu, G. Li, C. Li, H.-J. Wang, Y.-Q. Deng, M. Wu, M.-L. Cheng, Q. Ye, D.-Y. Xie, X.-F. Li, X. Wang, W. Shi, B. Hu, P.-Y. Shi, Z. Xu, C.-F. Qin, A single mutation in the prM protein of Zika virus contributes to fetal microcephaly. Science 358, 933-936 (2017).
6. V. Icheku, A review of the evidence linking Zika virus to the developmental abnormalities that lead to microcephaly in view of recent cases of birth defects in Africa. J. Mol. Pathol. Epidemiol. 2, S1 (2017).
7. J. J. Miner, B. Cao, J. Govero, A. M. Smith, E. Fernandez, O. H. Cabrera, C. Garber, M. Noll, R. S. Klein, K. K. Noguchi, I. U. Mysorekar, M. S. Diamond, Zika virus infection during pregnancy in mice causes placental damage and fetal demise. Cell 165, 1081-1091 (2016).
8. B. W. Jagger, J. J. Miner, B. Cao, A. Arora, A. M. Smith, A. Kovacs, I. U. Mysorekar, C. B. Coyne, M. S. Diamond, Gestational stage and IFN- signaling influence ZIKV infection in utero. Cell Host Microbe 22, 366-376 (2017).
9. F. R. Cugola, I. R. Fernandes, F. B. Russo, B. C. Freitas, J. L. M. Dias, K. P. Guimarães, C. Benazzato, N. Almeida, G. C. Pignatari, S. Romero, C. M. Polonio, I. Cunha, C. L. Freitas, W. N. Brandão, C. Rossato, D. G. Andrade, P. Faria Dde, A. T. Garcez, C. A. Buchpigel, C. T. Braconi, E. Mendes, A. A. Sall, P. M. Zanotto, J. P. Peron, A. R. Muotri, P. C. B. Beltrão-Braga, The Brazilian Zika virus strain causes birth defects in experimental models. Nature 534, 267-271 (2016).
10. L. J. Yockey, L. Varela, T. Rakib, W. Khoury-Hanold, S. L. Fink, B. Stutz, K. Szigeti-Buck, A. Van den Pol, B. D. Lindenbach, T. L. Horvath, A. Iwasaki, Vaginal exposure to Zika virus during pregnancy leads to fetal brain infection. Cell 166, 1247-1256.e4 (2016).
11. M. S. Vermillion, J. Lei, Y. Shabi, V. K. Baxter, N. P. Crilly, M. McLane, D. E. Griffin, A. Pekosz, S. L. Klein, I. Burd, Intrauterine Zika virus infection of pregnant immunocompetent mice models transplacental transmission and adverse perinatal outcomes. Nat. Commun. 8, 14575 (2017).
12. Centers for Disease Control and Prevention (CDC), Intrauterine West Nile virus infection-New York, 2002. MMWR. Morb. Mortal. Wkly. Rep. 51, 1135-1136 (2002).
13. S. G. Alpert, J. Fergerson, L. P. Noël, Intrauterine West Nile virus: Ocular and systemic findings. Am. J. Ophthalmol. 136, 733-735 (2003).
14. D. R. O’Leary, S. Kuhn, K. L. Kniss, A. F. Hinckley, S. A. Rasmussen, W. J. Pape, L. K. Kightlinger, B. D. Beecham, T. K. Miller, D. F. Neitzel, S. R. Michaels, G. L. Campbell, R. S. Lanciotti, E. B. Hayes, Birth outcomes following West Nile Virus infection of pregnant women in the United States: 2003-2004. Pediatrics 117, e537-e545 (2006).
15. J. G. Julander, Q. A. Winger, A. L. Olsen, C. W. Day, R. W. Sidwell, J. D. Morrey, Treatment of West Nile virus-infected mice with reactive immunoglobulin reduces fetal titers and increases dam survival. Antiviral Res. 65, 79-85 (2005).
16. A. Piantadosi, D. B. Rubin, D. P. McQuillen, L. Hsu, P. A. Lederer, C. D. Ashbaugh, C. Duffalo, R. Duncan, J. Thon, S. Bhattacharyya, N. Basgoz, S. K. Feske, J. L. Lyons, Emerging cases of Powassan virus encephalitis in New England: Clinical presentation, imaging, and review of the literature. Clin. Infect. Dis. 62, 707-713 (2016).
17. D. Nash, F. Mostashari, A. Fine, J. Miller, D. O’Leary, K. Murray, A. Huang, A. Rosenberg, A. Greenberg, M. Sherman, S. Wong, M. Layton; 1999 West Nile Outbreak Response Working Group, The outbreak of West Nile virus infection in the New York City area in 1999. N. Engl. J. Med. 344, 1807-1814 (2001).
18. L. R. Petersen, P. J. Carson, B. J. Biggerstaff, B. Custer, S. M. Borchardt, M. P. Busch, Estimated cumulative incidence of West Nile virus infection in US adults, 1999-2010. Epidemiol. Infect. 141, 591-595 (2013).
19. U.S. Geological Survey, Diseasemaps Dynamic Map Application (2017); https://diseasemaps.usgs.gov/mapviewer/.
20. K. Pedersen, E. Wang, S. C. Weaver, P. C. Wolf, A. R. Randall, K. R. Van Why, A. P. A. Travassos Da Rosa, T. Gidlewski, Serologic evidence of various arboviruses detected in white-tailed deer (Odocoileus virginianus) in the United States. Am. J. Trop. Med. Hyg. 97, 319-323 (2017).
21. R. A. Nofchissey, E. R. Deardorff, T. M. Blevins, M. Anishchenko, A. Bosco-Lauth, E. Berl, C. Lubelczyk, J. P. Mutebi, A. C. Brault, G. D. Ebel, L. A. Magnarelli, Seroprevalence of Powassan virus in New England deer, 1979-2010. Am. J. Trop. Med. Hyg. 88, 1159-1162 (2013).
22. T. Levi, F. Keesing, K. Oggenfuss, R. S. Ostfeld, Accelerated phenology of blacklegged ticks under climate warming. Philos. Trans. R. Soc. Lond. B Biol. Sci. 370, 20130556 (2015).
23. P. Gérardin, T. Couderc, M. Bintner, P. Tournebize, M. Renouil, J. Lémant, V. Boisson, G. Borgherini, F. Staikowsky, F. Schramm, M. Lecuit, A. Michault, Chikungunya virus-associated encephalitis: A cohort study on La Réunion Island, 2005-2009. Neurology 86, 94-102 (2016).
24. V. Karthiga, P. P. Kommu, L. Krishnan, Perinatal chikungunya in twins. J. Pediatr. Neurosci. 11, 223-224 (2016).
25. P. Gerardin, S. Samperiz, D. Ramful, B. Boumahni, M. Bintner, J.-L. Alessandri, M. Carbonnier, I. Tiran-Rajaoefera, G. Beullier, I. Boya, T. Noormahomed, J. Okoï, O. Rollot, L. Cotte, M.-C. Jaffar-Bandjee, A. Michault, F. Favier, M. Kaminski, A. Fourmaintraux, X. Fritel, Neurocognitive outcome of children exposed to perinatal mother-to-child Chikungunya virus infection: The CHIMERE cohort study on Reunion Island. PLOS Negl. Trop. Dis. 8, e2996 (2014).
26. P. Grivard, K. Le Roux, P. Laurent, A. Fianu, J. Perrau, J. Gigan, G. Hoarau, N. Grondin, F. Staikowsky, F. Favier, A. Michault, Molecular and serological diagnosis of Chikungunya virus infection. Pathol. Biol. 55, 490-494 (2007).
27. C. R. Anderson, W. G. Downs, G. H. Wattley, N. W. Ahin, A. A. Reese, Mayaro virus: A new human disease agent. II. Isolation from blood of patients in Trinidad. B.W.I. Am. J. Trop. Med. Hyg. 6, 1012-1016 (1957).
28. R. B. Tesh, D. M. Watts, K. L. Russell, C. Damodaran, C. Calampa, C. Cabezas, G. Ramirez, B. Vasquez, C. G. Hayes, C. A. Rossi, A. M. Powers, C. L. Hice, L. J. Chandler, B. C. Cropp, N. Karabatsos, J. T. Roehrig, D. J. Gubler, Mayaro virus disease: An emerging mosquito-borne zoonosis in tropical South America. Clin. Infect. Dis. 28, 67-73 (1999).
29. J. M. Richner, B. W. Jagger, C. Shan, C. R. Fontes, K. A. Dowd, B. Cao, S. Himansu, E. A. Caine, B. T. D. Nunes, D. B. A. Medeiros, A. E. Muruato, B. M. Foreman, H. Luo, T. Wang, A. D. Barrett, S. C. Weaver, P. F. C. Vasconcelos, S. L. Rossi, G. Ciaramella, I. U. Mysorekar, T. C. Pierson, P. Y. Shi, M. S. Diamond, Vaccine mediated protection against Zika virus-induced congenital disease. Cell 170, 273-283.e12 (2017).
30. G. Sapparapu, E. Fernandez, N. Kose, C. Bin, J. M. Fox, R. G. Bombardi, H. Zhao, C. A. Nelson, A. L. Bryan, T. Barnes, E. Davidson, I. U. Mysorekar, D. H. Fremont, B. J. Doranz, M. S. Diamond, J. E. Crowe, Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice. Nature 540, 443-447 (2016).
31. T. Oliphant, M. Engle, G. E. Nybakken, C. Doane, S. Johnson, L. Huang, S. Gorlatov, E. Mehlhop, A. Marri, K. M. Chung, G. D. Ebel, L. D. Kramer, D. H. Fremont, M. S. Diamond, Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Nat. Med. 11, 522-530 (2005).
32. H. Tang, C. Hammack, S. C. Ogden, Z. Wen, X. Qian, Y. Li, B. Yao, J. Shin, F. Zhang, E. M. Lee, K. M. Christian, R. A. Didier, P. Jin, H. Song, G.-l. Ming, Zika virus infects human cortical neural progenitors and attenuates their growth. Cell Stem Cell 18, 587-590 (2016).
33. A. S. Richard, B.-S. Shim, Y.-C. Kwon, R. Zhang, Y. Otsuka, K. Schmitt, F. Berri, M. S. Diamond, H. Choe, AXL-dependent infection of human fetal endothelial cells distinguishes Zika virus from other pathogenic flaviviruses. Proc. Natl. Acad. Sci. U.S.A. 114, 2024-2029 (2017).
34. A. A. Andersen, R. P. Hanson, Experimental transplacental transmission of St. Louis encephalitis virus in mice. Infect. Immun. 2, 320-325 (1970).
35. A. A. Andersen, R. P. Hanson, Intrauterine infection of mice with St. Louis encephalitis virus: Immunological, physiological, neurological, and behavioral effects on progeny. Infect. Immun. 12, 1173-1183 (1975).
36. Y. Fujisaki, Y. Miura, T. Sugimori, T. Morimoto, T. Ino, Experimental studies on vertical infection of mice with Japanese encephalitis virus. I. Effect of mouse strain on placental and fetal infection. Natl. Inst. Anim. Health Q. 16, 97-106 (1976).
37. A. Mathur, K. L. Arora, U. C. Chaturvedi, Congenital infection of mice with Japanese encephalitis virus. Infect. Immun. 34, 26-29 (1981).
38. K. F. Burns, Congenital Japanese B encephalitis infection of swine. Proc. Soc. Exp. Biol. Med. 75, 621-625 (1950).
39. U. C. Chaturvedi, A. Mathur, A. Chandra, S. K. Das, H. O. Tandon, U. K. Singh, Transplacental infection with Japanese encephalitis virus. J. Infect. Dis. 141, 712-715 (1980).
40. T. F. Tsai, R. Paul, M. C. Lynberg, G. W. Letson, Congenital yellow fever virus infection after immunization in pregnancy. J. Infect. Dis. 168, 1520-1523 (1993).
41. S. D. A. Nishioka, F. R. F. Nunes-Araujo, W. P. Pires, F. A. Silva, H. L. Costa, Yellow fever vaccination during pregnancy and spontaneous abortion: A case-control study. Trop. Med. Int. Health 3, 29-33 (1998).
42. J. Lindahl, S. Boqvist, K. Ståhl, H. T. V. Thu, U. Magnusson, Reproductive performance in sows in relation to Japanese Encephalitis Virus seropositivity in an endemic area. Tropl. Anim. Health Prod. 44, 239-245 (2012).
43. J. G. Julander, Q. A. Winger, L. F. Rickords, P.-Y. Shi, M. Tilgner, I. Binduga-Gajewska, R. W. Sidwell, J. D. Morrey, West Nile virus infection of the placenta. Virology 347, 175-182 (2006).
44. G. Pridjian, P. A. Sirois, S. McRae, A. F. Hinckley, S. A. Rasmussen, P. Kissinger, P. Buekens, E. B. Hayes, D. O’Leary, S. Kuhn, K. F. Swan, X. Xiong, D. M. Wesson, Prospective study of pregnancy and newborn outcomes in mothers with West Nile illness during pregnancy. Birth Defects Res. A Clin. Mol. Teratol. 106, 716-723 (2016).
45. P. A. Sirois, G. Pridjian, S. McRae, A. F. Hinckley, S. A. Rasmussen, P. Kissinger, P. Buekens, E. B. Hayes, D. R. O’Leary, K. F. Swan, X. Xiong, D. M. Wesson, Developmental outcomes in young children born to mothers with West Nile illness during pregnancy. Birth Defects Res. A Clin. Mol. Teratol. 100, 792-796 (2014).
46. M. Aubry, A. Teissier, M. Huart, S. Merceron, J. Vanhomwegen, C. Roche, A. L. Vial, S. Teururai, S. Sicard, S. Paulous, P. Despres, J.-C. Manuguerra, H.-P. Mallet, D. Musso, X. Deparis, V.-M. Cao-Lormeau, Zika Virus seroprevalence, French Polynesia, 2014-2015. Emerg. Infect. Dis. 23, 669-672 (2017).
47. M. Besnard, D. Eyrolle-Guignot, P. Guillemette-Artur, S. Lastère, F. Bost-Bezeaud, L. Marcelis, V. Abadie, C. Garel, M.-L. Moutard, J. M. Jouannic, F. Rozenberg, I. Leparc-Goffart, H.-P. Mallet, Congenital cerebral malformations and dysfunction in fetuses and newborns following the 2013 to 2014 Zika virus epidemic in French Polynesia. Euro Surveill. 21, 30181 (2016).
48. D. T. Cervantes, S. Chen, L. J. Sutor, S. Stonecipher, N. Janoski, D. J. Wright, M. P. Busch, West Nile virus infection incidence based on donated blood samples and neuroinvasive disease reports, Northern Texas, USA, 2012. Emerg. Infect. Dis. 21, 681-683 (2015).
49. M. P. Busch, D. J. Wright, B. Custer, L. H. Tobler, S. L. Stramer, S. H. Kleinman, H. E. Prince, C. Bianco, G. Foster, L. R. Petersen, G. Nemo, S. A. Glynn, West Nile virus infections projected from blood donor screening data, United States, 2003. Emerg. Infect. Dis. 12, 395-402 (2006).
50. N. Arora, Y. Sadovsky, T. S. Dermody, C. B. Coyne, Microbial vertical transmission during human pregnancy. Cell Host Microbe 21, 561-567 (2017).
51. J. M. Fox, F. Long, M. A. Edeling, H. Lin, M. K. S. van Duijl-Richter, R. H. Fong, K. M. Kahle, J. M. Smit, J. Jin, G. Simmons, B. J. Doranz, J. E. Crowe Jr., D. H. Fremont, M. G. Rossmann, M. S. Diamond, Broadly neutralizing alphavirus antibodies bind an epitope on E2 and inhibit entry and egress. Cell 163, 1095-1107 (2015).
52. R. Zhang, J. J. Miner, M. J. Gorman, K. Rausch, H. Ramage, J. P. White, A. Zuiani, P. Zhang, E. Fernandez, Q. Zhang, K. A. Dowd, T. C. Pierson, S. Cherry, M. S. Diamond, A CRISPR screen defines a signal peptide processing pathway required by flaviviruses. Nature 535, 164-168 (2016).
53. G. D. Ebel, I. Foppa, A. Spielman, S. R. Telford II, A focus of deer tick virus transmission in the northcentral United States. Emerg. Infect. Dis. 5, 570-574 (1999).
54. G. E. Nybakken, T. Oliphant, S. Johnson, S. Burke, M. S. Diamond, D. H. Fremont, Structural basis of West Nile virus neutralization by a therapeutic antibody. Nature 437, 764-769 (2005).
55. H. Zhao, E. Fernandez, K. A. Dowd, S. D. Speer, D. J. Platt, M. J. Gorman, J. Govero, C. A. Nelson, T. C. Pierson, M. S. Diamond, D. H. Fremont, Structural basis of Zika virus-specific antibody protection. Cell 166, 1016-1027 (2016).
56. A. Bayer, N. J. Lennemann, Y. Ouyang, J. C. Bramley, S. Morosky, E. T. D. A. Marques Jr., S. Cherry, Y. Sadovsky, C. B. Coyne, Type III interferons produced by human placental trophoblasts confer protection against Zika virus infection. Cell Host Microbe 19, 705-712 (2016).
57. S. A. Smith, L. A. Silva, J. M. Fox, A. I. Flyak, N. Kose, G. Sapparapu, S. Khomandiak, A. W. Ashbrook, K. M. Kahle, R. H. Fong, S. Swayne, B. J. Doranz, C. E. McGee, M. T. Heise, P. Pal, J. D. Brien, S. K. Austin, M. S. Diamond, T. S. Dermody, J. E. Crowe Jr., Isolation and characterization of broad and ultrapotent human monoclonal antibodies with therapeutic activity against chikungunya virus. Cell Host Microbe 18, 86-95 (2015).